 
                                                                                                    10/17/2025
                                            🎗 Cervical cancer remains one of the leading causes of cancer deaths among women in Nigeria—yet it is both preventable and treatable.
Through the Evidence-Informed Technical Advocacy for HPV Vaccine Introduction in Nigeria project, Management Sciences for Health and our partners Women Advocates for Vaccine Access and  Solina Centre for International Development and Research -SCIDaR are turning evidence into action—strengthening planning, financing, and policy for sustainable HPV vaccination.
🦠 HPV causes 95% of cervical cancer cases in Nigeria, making efforts to expand HPV vaccination essential to saving lives.
In recent weeks, MSH and partners hosted High-Level Policy Dialogues on Sustaining HPV Vaccination, bringing together government leaders, legislators, youth advocates, and community representatives to chart a long-term path for HPV vaccine financing and delivery.
📍 In  , we were honored to welcome the Honorable Commissioner for Health, who launched our Policy and Programmatic Recommendations (PPRs)—state-specific actions for sustainable HPV vaccine delivery—alongside the Special Adviser to the Governor on Health.
📍 In  , the First Lady, represented by her Chief of Staff, unveiled the PPRs and was decorated as HPV Vaccine Ambassador, highlighting strong state-level commitment. The event also featured the Commissioner for Health, the Emir of Zazzau, members of the House Committee on Health and PHC, and the State Primary Health Care Board—along with a powerful appeal from an adolescent girl calling for continued vaccine funding.
🌍 Next month, a national launch co-hosted with the National Primary Health Care Development Agency (NPHCDA) will build on these commitments and reinforce Nigeria’s leadership in eliminating cervical cancer.
👉 Learn more about our work to advance HPV vaccination and cervical cancer elimination: https://msh.org/projects/evidence-informed-technical-advocacy-for-hpv-vaccine-introduction-in-nigeria/  
 
                                                   
Evidence-Informed Technical Advocacy for HPV Vaccine Introduction in Nigeria Overview Nigeria has one of the highest burdens of cervical cancer in the
 
                                                                                                     
                                                                                                     
                                                                                                     
                                                                                                     
                                                                                                     
                                                                                                     
                                                                                                     
                                                                                                     
                                                                                                     
                                                                                                     
                                                                                                     
                                         
   
   
   
   
     
   
   
  